GUARDO, DANIELA
 Distribuzione geografica
Continente #
EU - Europa 517
Totale 517
Nazione #
IT - Italia 517
Totale 517
Città #
Genova 266
Genoa 140
Rapallo 101
Vado Ligure 6
Bordighera 4
Totale 517
Nome #
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients 129
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 118
Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia 114
Underlying CTLA4 deficiency in a patient with juvenile idiopathic arthritis and autoimmune lymphoproliferative syndrome features successfully treated with abatacept - A case report 48
The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders 45
Genetic screening of children with marrow failure. The role of primary Immunodeficiencies 28
Targeted ngs yields plentiful ultra-rare variants in inborn errors of immunity patients 21
Good tolerability of high dose colistin-based therapy in patients with haematological malignancies 20
Unexpected CD5+ B Cell Lymphocytosis during SARS-CoV-2 Infection: Relevance for the Pathophysiology of Chronic Lymphocytic Leukemia 15
Infection risk of Mycophenolate Mofetil and Sirolimus treatments in patients with Autoimmune Cytopenias and Primary Immuno-Regulatory Disorders. 9
Hematopoietic stem cell transplantation for inborn errors of immunity: 30-year single-center experience 3
Totale 550
Categoria #
all - tutte 2.600
article - articoli 2.561
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.161


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020102 0 2 4 12 11 15 14 10 12 12 8 2
2020/202140 2 3 2 1 6 3 0 7 3 4 2 7
2021/202279 1 1 6 7 2 6 2 10 11 16 3 14
2022/2023124 11 16 2 10 18 14 0 3 15 9 22 4
2023/2024124 0 10 2 15 12 13 8 20 7 4 21 12
2024/202510 8 2 0 0 0 0 0 0 0 0 0 0
Totale 550